Ewald Kolesnik

1.6k total citations
54 papers, 463 citations indexed

About

Ewald Kolesnik is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ewald Kolesnik has authored 54 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ewald Kolesnik's work include Diabetes Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (13 papers) and Heart Failure Treatment and Management (8 papers). Ewald Kolesnik is often cited by papers focused on Diabetes Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (13 papers) and Heart Failure Treatment and Management (8 papers). Ewald Kolesnik collaborates with scholars based in Austria, United States and Germany. Ewald Kolesnik's co-authors include Dirk von Lewinski, Markus Wallner, Harald Sourij, Martin Benedikt, Peter P. Rainer, Nicolas Verheyen, Douglas S. Scherr, Norbert J. Tripolt, Andreas Zirlik and Klemens Ablasser and has published in prestigious journals such as Circulation, PLoS ONE and Scientific Reports.

In The Last Decade

Ewald Kolesnik

50 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewald Kolesnik Austria 13 203 176 136 100 47 54 463
Gaetana Albanese Italy 9 189 0.9× 302 1.7× 241 1.8× 156 1.6× 39 0.8× 11 624
Monia Vezzoli Italy 9 170 0.8× 174 1.0× 124 0.9× 61 0.6× 32 0.7× 14 521
Mary K. Rude United States 8 152 0.7× 190 1.1× 128 0.9× 152 1.5× 30 0.6× 12 409
Camille Marciniak France 10 92 0.5× 81 0.5× 103 0.8× 102 1.0× 25 0.5× 27 332
Zhaowei Zhu China 11 127 0.6× 83 0.5× 109 0.8× 74 0.7× 38 0.8× 38 397
Alessia Buglioni United States 8 134 0.7× 100 0.6× 59 0.4× 58 0.6× 37 0.8× 24 278
Evanthia Bletsa Greece 10 154 0.8× 138 0.8× 109 0.8× 67 0.7× 53 1.1× 33 460
Annalisa Iervasi Italy 12 226 1.1× 379 2.2× 139 1.0× 97 1.0× 72 1.5× 15 602
K Forßmann Germany 10 231 1.1× 184 1.0× 111 0.8× 183 1.8× 139 3.0× 18 627
José Pablo Miramontes‐González Spain 15 55 0.3× 121 0.7× 136 1.0× 97 1.0× 73 1.6× 73 501

Countries citing papers authored by Ewald Kolesnik

Since Specialization
Citations

This map shows the geographic impact of Ewald Kolesnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewald Kolesnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewald Kolesnik more than expected).

Fields of papers citing papers by Ewald Kolesnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewald Kolesnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewald Kolesnik. The network helps show where Ewald Kolesnik may publish in the future.

Co-authorship network of co-authors of Ewald Kolesnik

This figure shows the co-authorship network connecting the top 25 collaborators of Ewald Kolesnik. A scholar is included among the top collaborators of Ewald Kolesnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewald Kolesnik. Ewald Kolesnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cejka, Vladimir, Ewald Kolesnik, David Zach, et al.. (2025). Prognostic Impact of Gait Speed, Muscle Strength and Muscle Mass in Chronic Heart Failure—A Prospective Cohort Study. ESC Heart Failure. 12(3). 2113–2124.
2.
Benedikt, Martin, Faisal Aziz, Ewald Kolesnik, et al.. (2024). Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with Empagliflozin. Scientific Reports. 14(1). 15083–15083. 1 indexed citations
3.
Zach, David, Markus Wallner, Dirk von Lewinski, et al.. (2024). Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study. Journal of Clinical Medicine. 13(19). 5966–5966. 7 indexed citations
4.
Kolesnik, Ewald, Markus Wallner, Klemens Ablasser, et al.. (2024). Impact of the Timing of Mechanical Circulatory Support on the Outcomes in Myocardial Infarction-Related Cardiogenic Shock: Subanalysis of the PREPARE CS Registry. Journal of Clinical Medicine. 13(6). 1552–1552. 1 indexed citations
5.
Zach, David, Alexander Peikert, Peter P. Rainer, et al.. (2024). The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure—A Prospective Study. Journal of Clinical Medicine. 13(7). 1930–1930. 5 indexed citations
6.
Aziz, Faisal, Norbert J. Tripolt, Peter N. Pferschy, et al.. (2024). Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial. Cardiovascular Diabetology. 23(1). 145–145. 10 indexed citations
7.
Benedikt, Martin, Ewald Kolesnik, Harald Sourij, & Dirk von Lewinski. (2023). SGLT2 Inhibition in Acute Myocardial Infarction—A Comprehensive Review. Reviews in Cardiovascular Medicine. 24(2). 32–32. 5 indexed citations
8.
Lewinski, Dirk von, Heiko Bugger, Ewald Kolesnik, et al.. (2023). Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort. Journal of Clinical Medicine. 12(22). 6988–6988. 2 indexed citations
9.
Posch, Florian, Markus Wallner, Peter P. Rainer, et al.. (2023). Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort. European Journal of Internal Medicine. 118. 73–81. 2 indexed citations
10.
Reiter, Clemens, Gert Reiter, Ewald Kolesnik, et al.. (2023). Impact of the evaluation method on 4D flow-derived diastolic transmitral and myocardial peak velocities: Comparison with echocardiography. European Journal of Radiology. 170. 111247–111247. 2 indexed citations
11.
Lewinski, Dirk von, Ewald Kolesnik, Faisal Aziz, et al.. (2023). Timing of SGLT2i initiation after acute myocardial infarction. Cardiovascular Diabetology. 22(1). 269–269. 12 indexed citations
12.
Reiter, Clemens, Ursula Reiter, Ewald Kolesnik, et al.. (2023). MR 4D flow–derived left atrial acceleration factor for differentiating advanced left ventricular diastolic dysfunction. European Radiology. 34(6). 4065–4076. 3 indexed citations
13.
Verheyen, Nicolas, Kathrin Danninger, Franz Duca, et al.. (2022). Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study. Biomedicines. 10(12). 3052–3052. 2 indexed citations
14.
Kolesnik, Ewald, H. Maechler, Brigitte Pelzmann, et al.. (2022). miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium. International Journal of Molecular Sciences. 23(13). 6962–6962. 2 indexed citations
15.
Posch, Florian, Philipp Jud, Jakob M. Riedl, et al.. (2022). Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis. Frontiers in Cardiovascular Medicine. 9. 808605–808605. 4 indexed citations
16.
Trummer, Olivia, Ines Foessl, Natascha Schweighofer, et al.. (2022). Expression Profiles of miR-22-5p and miR-142-3p Indicate Hashimoto’s Disease and Are related to Thyroid Antibodies. Genes. 13(2). 171–171. 13 indexed citations
17.
Schweighofer, Natascha, Christoph Haudum, Olivia Trummer, et al.. (2022). Dp-ucMGP as a Biomarker in Sarcopenia. Nutrients. 14(24). 5400–5400. 6 indexed citations
18.
Zach, David, Klemens Ablasser, Ewald Kolesnik, et al.. (2021). Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry. Genes. 12(10). 1469–1469. 12 indexed citations
19.
Gager, Gloria M., Bernd Jilma, Max‐Paul Winter, et al.. (2020). Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients. European Journal of Clinical Investigation. 50(11). e13304–e13304. 9 indexed citations
20.
Winter, Max‐Paul, Dirk von Lewinski, Markus Wallner, et al.. (2019). Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study. Scientific Reports. 9(1). 8194–8194. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaetana Albanese Breakdown of academic impact, for papers by Monia Vezzoli Breakdown of academic impact, for papers by Mary K. Rude Breakdown of academic impact, for papers by Camille Marciniak Breakdown of academic impact, for papers by Zhaowei Zhu Breakdown of academic impact, for papers by Alessia Buglioni Breakdown of academic impact, for papers by Evanthia Bletsa Breakdown of academic impact, for papers by Annalisa Iervasi Breakdown of academic impact, for papers by K Forßmann Breakdown of academic impact, for papers by José Pablo Miramontes‐González
Rankless by CCL
2026